Company Valuation: DNA Investment

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 43,200 56,400 52,800
Change - 30.56% -6.38%
Enterprise Value (EV) 1 20,569 20,665 44,465
Change - 0.47% 115.17%
P/E 280x -79x 100x
PBR 0.36x 0.47x 0.44x
PEG - 0x -1x
Capitalization / Revenue 0.83x 1.2x 1.59x
EV / Revenue 0.39x 0.44x 1.34x
EV / EBITDA -9.49x 4.64x 23.2x
EV / EBIT -7.74x -579x -27.6x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 12.86 -59.47 43.89
Distribution rate - - -
Net sales 1 52,358 47,137 33,191
EBITDA 1 -2,169 4,458 1,921
EBIT 1 -2,658 -35.71 -1,612
Net income 1 154.4 -713.6 526.7
Net Debt 1 -22,631 -35,735 -8,335
Reference price 2 3,600.00 4,700.00 4,400.00
Nbr of stocks (in thousands) 12,000 12,000 12,000
Announcement Date 3/21/25 A 3/21/25 A 3/31/26 A
1VND in Million2VND
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 2.53M
18.94x3.37x12.21x3.85% 47.57B
30.32x4.5x19.08x1.12% 26.44B
19.25x2.34x12.66x4.7% 12.95B
15.85x1.74x9.95x3.7% 5.23B
22.62x1.12x8.5x1.62% 3.65B
13.64x1.62x9.73x10.05% 3.21B
33.57x4.05x22.46x - 2.94B
98.34x1.53x61.23x3.42% 2.06B
Average 31.57x 2.53x 19.48x 4.07% 12B
Weighted average by Cap. 23.67x 3.30x 14.95x 3.34%

Y-o-Y evolution of P/E

Valuation ratios - P/E - DNA Investment

Historical PBR trend

Valuation ratios - PBR - DNA Investment

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - DNA Investment

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - DNA Investment

  1. Stock Market
  2. Stocks
  3. KSD Stock
  4. Valuation DNA Investment